In this episode, Cameron Kiani interviews Ken Gillman, MD, on using Monoamine Oxidase Inhibitors in clinical practice. Dr. Gillman is a Queensland-based psychiatrist considered to be one of the world's leading experts on MAOIs. He recently published a statement "Revitalizing monoamine oxidase inhibitors: a call for action" in the journal CNS Spectrums. Cameron Kiani is a fourth year medical student at Icahn School of Medicine at Mount Sinai with an interest in treatment-resistant mood disorders. "Revitalizing monoamine oxidase inhibitors: a call for action" https://www.cambridge.org/core/journals/cns-spectrums/article/revitalizing-monoamine-oxidase-inhibitors-a-call-for-action/32497C0FE4F08D0D4C07E6350A91B0EE

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related